Antrum Biotech have over a decade of experience in developing infectious disease diagnostic tests with a strong focus on Tuberculosis. Skilled in identifying the patient need and clinical outcome required, niche tests are designed and developed from discovery stage. The IRISA-TB test for extra-pulmonary tuberculosis is just one of the many innovations in the pipeline. Get in touch if you are keen to make a difference to our mission to meet the EndTB 2030 goals and leave your mark in this space! In our small way, we are a global contributor to innovation in healthcare by translating infectious diseases research into high impact solutions. We specialise in diagnostic test R&D and work from target discovery to delivery of quality products that save lives and improve patient outcomes. We are recognised as award-winners for leading Research to Innovation by the National Science and Technology Forum in South Africa and have led flagship projects with the South African National Biosciences, the SA Medical Research Council and the Department of Science and Innovation. Contact us for more details on the IRISA-TB™ test to diagnose extra-pulmonary tuberculosis and the other TB diagnostic tests under development.
